Jill Stein

Articles

Bone Monitoring Is Essential With Exemestane Use for Primary Prevention of Breast Cancer

April 23rd 2012

Monitoring bone health and ensuring adequate calcium and vitamin D intake in postmenopausal women who are taking exemestane for the primary prevention of breast cancer is essential.

Addition of Oxaliplatin to Adjuvant Therapy for Late-Stage Colon Cancer Shows Benefit in Real-World Setting

April 13th 2012

Adding oxaliplatin to conventional chemotherapy increases survival in patients with advanced colon cancer in a broad range of community practice settings.

Many Patients Continue to Smoke After Cancer Diagnosis

April 11th 2012

Being newly diagnosed with lung or colorectal cancer is often not sufficient to motivate cigarette smokers to quit.

Chemotherapy-Related Fatigue Persists Over Time

April 4th 2012

Patients who undergo chemotherapy for breast cancer may develop fatigue that remains problematic long after they complete treatment.

Preoperative Chemotherapy Shows Promise in Early Lung Cancer

March 28th 2012

Preoperative gemcitabine plus cisplatin followed by radical surgery is feasible, tolerable, and active in patients with early-stage non-small cell lung cancer.

Prediagnostic Obesity Curbs Colorectal Cancer Survival

March 27th 2012

Patients who are obese before being diagnosed with colorectal cancer are more likely to die of their disease than patients who are at a normal weight prediagnosis.

Improved Survival in Women With Invasive Epithelial Ovarian Cancer and Germline BRCA Gene Mutations

March 26th 2012

Researchers are reporting better survival rates in women with invasive EOC and germline mutations in the tumor suppressor genes BRCA1 and BRCA2 than in patients who are noncarriers.

Acupuncture Shows Potential for Xerostomia

March 13th 2012

Acupuncture may help prevent xerostomia in patients with nasopharyngeal carcinoma undergoing radiotherapy and may also reduce symptom severity.

Nonmalignant Late Effects Pose Heavy Burden After Hematopoietic Cell Transplant

March 9th 2012

The burden of late complications after hematopoietic cell transplantation is high, and these late effects are associated with poor health and decreased functional status.

Everolimus Plus Octreotide LAR Is Effective in Advanced Neuroendocrine Tumors

March 8th 2012

Combination therapy with everolimus and the octreotide LAR increases the median PFS in patients with advanced neuroendocrine tumors associated with carcinoid syndrome.

No Increased Risk of Cardiovascular Death With Androgen Deprivation Therapy for Prostate Cancer

March 7th 2012

A meta-analysis shows no apparent association between androgen deprivation therapy and cardiovascular events and death in men with prostate cancer.

Baseline Glucose Levels in Older Women May Be Linked to Colorectal Cancer Risk

February 29th 2012

New findings suggest that increased serum glucose levels may be a risk factor for colorectal cancer in postmenopausal women.

Yearly Prostate Cancer Screening Does Not Provide Mortality Benefit

February 28th 2012

Annual prostate cancer screening does not decrease mortality from prostate cancer more than opportunistic screening.

Premature Tamoxifen Withdrawal Is Common in Male Patients With Breast Cancer

February 20th 2012

New data show that roughly one-fifth of tamoxifen-treated male patients with breast cancer stop treatment early because of side effects.

Outpatient Treatment Approved for Low-Risk Febrile Neutropenia

February 16th 2012

Outpatient management in patients with cancer who have a low risk of severe febrile neutropenia is an effective and safe option to standard inpatient treatment.

Navigation Program Shows Limited Benefit in Underserved, Urban Women With Breast Cancer

February 15th 2012

The use of a navigation program for an urban safety net breast cancer population has only a moderate effect on the time from symptom presentation to treatment.

Breast Cancer is Diagnosed Later in Men but Is Less Often Fatal

February 14th 2012

New data show that while men are diagnosed with breast cancer at a mere fraction of the rate of women, they tend to have more advanced disease at the time of diagnosis.

Radiation Added to Hormone Therapy Bests Hormone Therapy Alone for High-Risk Prostate Cancer

February 9th 2012

Radiation therapy added to androgen deprivation therapy prolongs overall survival in men with locally advanced or otherwise high-risk prostate cancer.

Transplant Recipients Have Higher Risk of Diverse Cancers

February 8th 2012

Patients who receive a solid organ transplant have about twice the risk of developing cancer as the general population.

Addition of Bevacizumab May Help in Nasopharyngeal Cancer

February 7th 2012

Researchers are reporting favorable early results with the addition of bevacizumab to conventional chemoradiation in patients with advanced nasopharyngeal cancer.